EzumeImages/iStock via Getty Images
The purpose of literature is to turn blood into ink. ― T.S. Eliot
Today, we take an in-depth look at Global Blood Therapeutics (GBT). The company has a new compound on the market targeting Sickle Cell Disease or SCD….
Global Blood Therapeutics: It Might Be Time To Buy The Dip
Share this article
More News

What to Know — JournalArta Global
October 12, 2026



Moderna Inc Stock (MRNA) Moved Up by 7.63% on Oct 9: A Full Analysis
October 12, 2026

Bitget Wallet vs exchange: who signs your transfer
October 12, 2026
